Current trends in lipid based delivery systems and its applications in drug delivery

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue SUPPL. 3, 2012, Pages 4-9

  Saroj, Soumya ^a   Baby, Doney Alex ^a   Sabitha, M ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Archaeosomes; Emulsions; Lipid based delivery system; Vesosomes

Indexed keywords

ACICLOVIR; AMPRENAVIR; ARCHAESOME; BEXAROTENE; CALCITRIOL; CYCLOSPORIN A; DRUG CARRIER; ESTRADIOL; ETHOSOME; FENOFIBRATE; GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; IMMUNOLIPOSOME; INDINAVIR; INSULIN; LAMIVUDINE; LIDOCAINE; LIPOSOME; MELOXICAM; NANOPARTICLE; PROPRANOLOL; RITONAVIR; SAQUINAVIR; TAMOXIFEN; TETRACAINE; TRANSFERSOME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VALSARTAN; VESOSOME; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIODEGRADATION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG SAFETY; DRUG STABILITY; HERPES SIMPLEX; HUMAN; LIPID BASED DELIVERY SYSTEM; MICROEMULSION; MONITORING; NANOEMULSION; PICKERING EMULSION; REVIEW; SELF EMULSIFYING DELIVERY SYSTEM; SOLUBILIZATION; TOXICITY; VESICULAR DRUG DELIVERY SYSTEM;

EID: 84874744098     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Amidon GL., Lennernas H., Shah VP, Crison JR. A theoretical basis for a biopharmaceutical drug classification: The correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res., 1995;12:413-419
2. H Lautenschlager, Kosmetik International, 2004;11:46-48.
3. Souto EB, Muller RH. Nanoparticulate Drug Delivery Systems, Informa Healthcare USA, Inc. 2007;166:213-234
4. Chandra A. Microemulsions: An Overview Retrieved from http://www.pharmainfo.net/reviews/microemulsions-overview,1992
5. Shinoda K, Lindman B. Organised surfactant systems: microemulsions, Langmuir 1987;3:135-149
6. Lawrence J, Rees G. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev.,2000; 45: 89-121.
7. Kasiraman Krishnan, Bryan Chapman, Frank S. Bates, and Timothy P. Lodge, Effects of shear flow on a polymeric bicontinuous microemulsion: Equilibrium and steady state behaviour Journal of Rheology 2002;46(2):529.
8. Rohit R Shah, Chandrakant S Magdum, Kiran A Wadkar, Nilofar S Naikwade. Fluconazole Topical Microemulsion: Preparation and Evaluation, Research J. Pharm. and Tech. 2009;2 (2):353-357
9. Morey TE, Modell JH, Shekhawat D, Grand T, Shah DO, Gravenstein N, McGorray SP, Dennis DM. Preparation and anesthetic properties of propofol microemulsions in rats, Anesthesiology.2006;104(6):1184-90
10. Fathy I Abdallahi, Hamdy M. Dawabai, Ahmed Mansour, Ahmed M Samyi. Evaluation of antiinflamatory and analgesic effects of Piroxicam loaded Microemulsion in topical formulation, International Journal of Pharmacy and Pharmaceutical Sciences.2011; 3(2):66-70.
11. Pouton CW. Formulation of self emulsifying drug delivery system. Advanced drug delivery Review.1997;25:45-47
12. Rajan B Mistryl, Nirav S Sheth. A review: self emulsifying drug delivery system. International Journal of Pharmacy and Pharmaceutical Sciences 2011;3(2):23-28
13. El-Kamel AH, et al. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm.2001;220:13-21
14. Shah NH, et al. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving invitro dissolution and oral absorption of lipophilic drugs. Int J Pharm.1994; 106:15-23.
15. Tenjarla SN. Microemulsions: An overview and pharmaceutical applications. Critical Reviews in Therapeutic Drug Carrier Systems.1999; 16:461-521.
16. Devarajan V, Ravichandran V. Nanoemulsions: as modified drug delivery tool. International journal of comprehensive pharmacy.2011;4(1):1-6
17. Abhijit A Date, Neha Desai, Rahul Dixit, Mangal Nagarsenker. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. 2010;5(10)1595-1616
18. Schmid D, Zulli F. Cosmetics & Toiletries. 2007;122(1):71-76.
19. Hamouda T, Cao Z, Tonda R, Johnson K, Wright CD, Brisker J, Baker JR Jr. A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J Infect Dis 1999;180(6):1939-49
20. Frelichowska J, Bolzinger MA. et al. Int. J. Pharm. 2009;371:56-63.
21. Velikov KP, Velev OD. Stabilization of thin films, foams, emulsions and bifluid gels with surface-active solid particles: In Colloid Stability and Application in Pharmacy. Wiley-VCH Publ. Weinheim, 2007:277-306
22. Binks BP, Fletcher PDI. Particles Adsorbed at the Oil-Water Interface: A Theoretical Comparison between Spheres of Uniform Wettability and "Janus" Particles. Langmuir. 2001;17:4708-4710
23. Frelichowska J, Chevalier Y et al. Int. J. Pharm. 2009;368:7-15.
24. Blume G. Cevc, G. Liposomes for sustained drug release in vivo. Biochim. Biophys. Acta. 1990;1029:91-97.
25. Banerjee R. Liposomes: Applications in Medicine. J Biomater Appl. 2001; 16(1):3-21
26. Bombardelli E, Curri SB, Loggia Della R, Del NP, Tubaro A, Gariboldi P. Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia. 1989; 60:1-9
27. Gabetta B, Bombardelli E, Pifferi G. Complexes of flavanolignans with phospholipids preparation, thereof and associated pharmaceutical compositions. U. S. patent No. 4764508, 1986
28. Bombardelli E, Spelta M, Loggia Della R, Sosa S, Tubaro A. Aging Skin: Protective effect of silymarin-PHYTOSOME. Fitoterapia 1991; 62(2): 115-22
29. Vitamedics, Phytosome Products, Available at http://www.vitamedics.com. Accessed-Sept. 19, 2008
30. Cevc G, Blume G., Schatzlein A: Transfersomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. Journal of Controlled Release. 1997; 45:211-226
31. Boinpally RR., Zhou SL, Poondru S, Devraj G, Jasti BR. Lecithin vesicles for topical delivery of diclofenac. European Journal of Pharmaceutics and Biopharmaceutics. 56: 389-392
32. Gregor Cevc, Dieter Gebauer, Juliane Stieber, Andreas Schätzlein, Gabriele Blume. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin; Biochimica et Biophysica Acta. 1998; 1368:201-215
33. Hofer C, Hartung R, Gobel R, Deering P, Lehmer A, Breul J. New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspects. World J. Surg. 2000;24:1187-1189
34. Sunil Mahor, Amit Rawat, Praveen K Dubey, Prem N, Gupta, Kapil Khatri, Amit K. Goyal, S P. Vyas Cationic transfersomes based topical genetic vaccine against hepatitis B. International Journal of Pharmaceutics 2007; 340:13-19
35. Touitou E, Inventor. Copmosition of applying active substance to or through skin, US patent 5 540 934, 1996 july 30
36. Patel S, Etosomes: a promising tool for transdermal delivery of drug, Pharma Info Net. 2007;5(3)
37. Jain S, Umamaheshwari RB, Bhadra D, Jain NK, ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent, Ind J Pharma Sci, 2004;66:72-81
38. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M, Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release. 2000; 65:403-418
39. Subheet Jain, Ashok K Tiwary, Bharathi Sapra, Narendra K Jain. Fornulation and evaluation of ethosomes for transdermal delivery of Lamivudine. AAPS pharma scitech 2007 oct;8(4):249-257
40. Bhalaria MK, Sachin Naik, Misra AN. Ethosomes: A novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian Journal of Experimental Biology. 2009;47:368-375
41. Kates M. Biology of halophilic bacteria, Part II. Membrane lipids of extreme halophiles: biosynthesis, function and evolutionary significance. Experientia 1993;49:1027-1036
42. Mathai JC, Sprott GD, Zeidel ML: Molecular mechanisms of water and solute transport across archaebacterial lipid membranes. J Biol Chem 2001;276:27266-27271
43. Vossenberg JL van de, Driessen AJ, Grant WD, Konings WN: Lipid\ membranes from halophilic and alkali-halophilic Archaea have a low H+ and Na+ permeability at high salt concentration. Extremophiles 1999;3:253-257
44. Omri A, Makabi-Panzu B, Agnew BJ, Sprott GD and Patel GB, Influence of coenzyme Q10 on tissue distribution of archaeosomes and pegylated archaeosomes administered to mice by oral and intravenous routes. J Drug Target. 2000;7: 383-392
45. Omri A, Agnew BJ and Patel GB, Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes. Int J Toxicol 2003;22: 9-23
46. Kisak, E. Coldren, B. Zasadzinski JA. Langmuir. 2002;18: 284.
47. Evans CA, Zasadzinski JA. Langmuir. 2003;19:3109.
48. Xu, G, Martinez JS, Groves JT, Butler A. J. Am. Chem. Soc. 2002;124:13408-13415
49. Séverine Jaspart, Pascal Bertholet, Luc Delattre, Brigitte Evrard. Study of solid lipid microparticles as sustained release delivery system for pulmonary administration.2001;23:34-45
50. Iannuccelli V, Coppi G et al.J. Appl. Cosmetol.2001;19:113-119
51. Sedef Erdal M, Sevgi Güngör, Yi{dotless}ldi{dotless}z Özsoy, Ahmet Araman. Preparation and in vitro evaluation of indomethacin loaded solid lipid microparticles. Acta Pharmaceutica Sciencia. 2009;51: 203-210
52. Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002; 242: 121-128
53. Muller RH, Runge SA. Solid lipid nanoparticles (SLN) for controlled drug delivery: Submicron emulsions in drug targeting and delivery, Eur. J. Pharm. 1995;41:62-69
54. Jenning V, Gysler A, Schafer-Korting M, Gohla S. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49:211-8
55. Souto EB, Muller RH. Int. J. Cosmet. Sci. 2008;30:157-165
56. Mehnert M, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001; 47: 165-196
57. Morel S, Terreno E, Ugazio E, Aime S, Gasco MR. NMR relaxometric investigations of lipid nanoparticles (SLN) containing gadolinium (III) complexes. Eur J Pharm Biopharm. 1998;45:157-63
58. Plianbangchang P, Tungpradit W et al. Naresuan University Journal.2007;15(2):73-81
59. Olbrich C, Kayser O, Muller RH, Lipase degradation of Dynasan 114and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int. J. Pharm. 2002;237:119-128
60. Trombinoa S, Cassano R et al. Colloids and Surfaces B:Biointerfaces. 2009;72:181-187
61. Ruktanonchai U, Bejrapha P et al., aaps PharmSciTech, 10(1), 224-227 (2009).
62. Yang S, Zhu J, Lu Y, Liang B, Yang C. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res. 1999;16(5):751-757
63. Zara GP, Bargoni A, Cavelli R, Fundaro A, Vighetto D, Gasco MR, Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J. Pharm. Sci.2002;91(5): 1324-1333
64. Schafer-Korting M, Mehnert W et al., Adv. Drug Del. Rev. 2007;59: 427-443